The U.S. National Institutes of Health HIV guidelines recommend starting ART within 2 weeks of anti-TB chemotherapy for HIV-TB co-infected patients with CD4 cell counts <50 cells/ μL and within 8 weeks for CD4 counts >50 cells/μL109. This evidence concerns the gene CD4 and tuberculosis.